Robert Wood Johnson Foundation Clinical Scholars, University of Michigan, Ann Arbor, Michigan 48109-2800, USA.
Thyroid. 2013 Jun;23(6):727-33. doi: 10.1089/thy.2012.0218. Epub 2013 May 28.
Traditionally, thyroid surgery has been an inpatient procedure due to the risk of several well-documented complications. Recent research suggests that for selected patients, outpatient thyroid surgery is safe and feasible, with the additional potential benefit of cost savings. In recognition of these observations, we hypothesized that there would be an increase in U.S. outpatient thyroidectomies with a concurrent decline in inpatient thyroidectomies over time.
Comparative cross-sectional analyses of the National Survey of Ambulatory Surgery (NSAS) and Nationwide Inpatient Sample (NIS) databases from 1996 and 2006 were performed. All cases of thyroid surgery were extracted, as well as data on age, sex, and insurance status. Diagnoses and surgical cases were identified using International Classification of Diseases, Ninth Revision (ICD-9) diagnostic and treatment codes. Hospital charges were acquired from the NIS 1996 and 2006 and NSAS 2006 releases, using imputed data where necessary. After survey weights were applied, patient characteristics, diagnoses, and procedures were compared for inpatient versus outpatient procedures.
The total number of thyroidectomies increased 39%, from 66,864 to 92,931 cases per year during the study timeframe. Outpatient procedures increased by 61%, while inpatient procedures increased by 30%. The proportion of privately insured inpatients declined slightly from 63.8% to 60.1%, while those covered by Medicare increased from 22.8% to 25.8%. In contrast, the proportion of privately insured outpatients declined sharply from 76.8% to 39.9%, while those covered by Medicare rose from 17.2% to 45.7%. These trends coincided with a small increase in the mean inpatient age from 50.2 to 52.3 years and a larger increase in the mean outpatient age from 50.7 to 58.1 years. Inflation-adjusted per-capita charges for inpatient thyroidectomies more than doubled from $9,934 in 1996 to $22,537 in 2006, while aggregate national inpatient charges tripled from $464 million to $1.37 billion. By comparison, per-capita charges for outpatient thyroidectomy totaled $7,222 in 2006.
From 1996 to 2006, there has been a concurrent modest increase in inpatient and pronounced increase in outpatient thyroidectomies in the United States, with a consequential demographic shift and economic impact.
由于有几种记录在案的并发症风险,传统上甲状腺手术一直是住院手术。最近的研究表明,对于某些选定的患者,门诊甲状腺手术是安全且可行的,并且具有节省成本的额外潜在益处。鉴于这些观察结果,我们假设随着时间的推移,美国门诊甲状腺切除术的数量会增加,而住院甲状腺切除术的数量会同时减少。
对 1996 年和 2006 年全国门诊手术调查(NSAS)和全国住院患者样本(NIS)数据库进行了比较性横断面分析。提取了所有甲状腺手术病例,以及年龄、性别和保险状况数据。使用国际疾病分类,第九修订版(ICD-9)诊断和治疗代码来识别诊断和手术病例。从 NIS 1996 年和 2006 年以及 NSAS 2006 年的版本中获取了医院费用,必要时使用了估算数据。应用调查权重后,对住院与门诊手术的患者特征、诊断和手术进行了比较。
研究期间,甲状腺切除术的总数增加了 39%,从每年 66864 例增加到 92931 例。门诊手术增加了 61%,而住院手术增加了 30%。私人保险住院患者的比例略有下降,从 63.8%降至 60.1%,而医疗保险覆盖的患者比例从 22.8%增至 25.8%。相比之下,私人保险门诊患者的比例急剧下降,从 76.8%降至 39.9%,而医疗保险覆盖的患者比例从 17.2%增加到 45.7%。这些趋势与平均住院患者年龄从 50.2 岁略微增加到 52.3 岁和平均门诊患者年龄从 50.7 岁显著增加到 58.1 岁相吻合。经通胀调整后,住院甲状腺切除术的人均费用从 1996 年的 9934 美元增加到 2006 年的 22537 美元,而全国住院费用则从 4.64 亿美元增加到 13.7 亿美元。相比之下,2006 年门诊甲状腺切除术的人均费用为 7222 美元。
从 1996 年到 2006 年,美国的住院和门诊甲状腺切除术同时适度增加,门诊手术明显增加,同时带来了人口统计学的转变和经济影响。